AstraZeneca has announced promising results from the BATURA Phase IIIb trial, showcasing the effectiveness of AIRSUPRA ...
Taking aspirin regularly cuts the risk of developing pancreatic cancer by 40% in people with diabetes and by 20% in the ...
Bayer is seeking EMA approval for darolutamide in metastatic hormone-sensitive prostate cancer, building on promising Phase ...
Bayer announced the submission of an application to the European Medicines Agency for the oral androgen receptor inhibitor ...
Regular use of aspirin may cut the risk of pancreatic cancer in people with diabetes by 40%, a study has found. It may also ...
Back in 1974, Lil’ Drug Store began with a simple value proposition: “If you’re driving down the road and you have a headache ...
Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...